Loading company details…
PHAIM LTD develops a novel therapeutic platform called Antigenic Immune Modulation (AIM) that aims t Sign up to read more
Profile updated Jul 2026
No share issues or funding rounds.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| ANDREA MANSON | ORDINARY | 50 | 50.0% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
1 more shareholder on file , sign up free to see.
Companies with the most similar business descriptions.
These are the directors and secretaries who have left PHAIM LTD. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.